Re: 'Is a randomized trial of a short course of aminoglycoside added to beta-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?' Pharmacokinetic/pharmacodynamic considerations
Author(s)
Heffernan, A
Lipman, J
Roberts, J
Griffith University Author(s)
Year published
2018
Metadata
Show full item recordAbstract
Dear Sir,
We read with interest the comments from Ong et al. [1] regarding the need for a well-designed randomized controlled trial (RCT) to provide evidence to guide clinicians regarding the use of combined β-lactam antibiotic and aminoglycoside therapy for the management of critically ill patients with sepsis or septic shock. We would like to highlight the importance of appropriate dosing strategies and the inclusion of pharmacokinetic/pharmacodynamic (PK/PD) sub-studies to provide further evidence about the potential utility of combination therapy.Dear Sir,
We read with interest the comments from Ong et al. [1] regarding the need for a well-designed randomized controlled trial (RCT) to provide evidence to guide clinicians regarding the use of combined β-lactam antibiotic and aminoglycoside therapy for the management of critically ill patients with sepsis or septic shock. We would like to highlight the importance of appropriate dosing strategies and the inclusion of pharmacokinetic/pharmacodynamic (PK/PD) sub-studies to provide further evidence about the potential utility of combination therapy.
View less >
View less >
Journal Title
Clinical Microbiology and Infection
Volume
24
Issue
6
Subject
Clinical sciences
Science & Technology
Life Sciences & Biomedicine
Infectious Diseases
Microbiology
NOSOCOMIAL PNEUMONIA